Clonazepam Tablet
Product Images NDC 70518-3960

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clonazepam (NDC 70518-3960). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

ClonazePAM 0.5 mg tablet packaging label showing 100 tablets per box. The label includes the C-IV schedule classification and is marked RX only. Manufactured by Aurobindo in India and repackaged by RemedyRepack Inc., Indiana, PA. The label features a barcode, QR code, and directions to see the package insert.*

FDA Label Image

Mm2 (Clonazepam 0.5mg 70518 3960 01)

Clonazepam 0.5 mg tablet packaging label showing brand name ClonazePAM, dosage strength 0.5 mg, quantity of 1 tablet, and classification as Schedule IV (C-IV). Labeler is RemedyRepack Inc. with manufacturing information listing Aurobindo, Nagar, India. Label includes instruction to see package insert and standard cautions about federal transfer law and storage conditions.*

FDA Label Image

Chemical Structure (Clonazepam Str)

Chemical structure of clonazepam, showing its benzodiazepine core with nitro and chloro substituents on the aromatic rings as depicted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.